vs
HNI CORP（HNI）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是HNI CORP的1.1倍（$772.1M vs $683.8M），Revvity净利率更高（12.7% vs 6.0%，领先6.7%），Revvity同比增速更快（5.9% vs 1.7%），Revvity自由现金流更多（$161.8M vs $135.6M），过去两年Revvity的营收复合增速更高（9.0% vs 0.3%）
HNI公司是全球营收规模领先的办公家具制造商之一，同时也是全球壁炉产品行业的头部企业，生产销售燃气、电、燃木及生物质燃料壁炉、嵌入式炉具、取暖炉、饰面及相关配件。公司1944年由工程师C.麦克斯韦·斯坦利等三人联合创立，总部位于美国爱荷华州马斯卡廷。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
HNI vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.1倍
$683.8M
营收增速更快
RVTY
高出4.1%
1.7%
净利率更高
RVTY
高出6.7%
6.0%
自由现金流更多
RVTY
多$26.2M
$135.6M
两年增速更快
RVTY
近两年复合增速
0.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $683.8M | $772.1M |
| 净利润 | $41.2M | $98.4M |
| 毛利率 | 42.1% | — |
| 营业利润率 | 9.4% | 14.5% |
| 净利率 | 6.0% | 12.7% |
| 营收同比 | 1.7% | 5.9% |
| 净利润同比 | -13.3% | 3.9% |
| 每股收益（稀释后） | $0.88 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HNIRVTY
| Q4 25 | — | $772.1M | ||
| Q3 25 | $683.8M | $698.9M | ||
| Q2 25 | $667.1M | $720.3M | ||
| Q1 25 | $599.8M | $664.8M | ||
| Q4 24 | $642.5M | $729.4M | ||
| Q3 24 | $672.2M | $684.0M | ||
| Q2 24 | $623.7M | $691.7M | ||
| Q1 24 | $588.0M | $649.9M |
净利润HNIRVTY
| Q4 25 | — | $98.4M | ||
| Q3 25 | $41.2M | $46.7M | ||
| Q2 25 | $48.2M | $53.9M | ||
| Q1 25 | $13.9M | $42.2M | ||
| Q4 24 | $38.3M | $94.6M | ||
| Q3 24 | $47.5M | $94.4M | ||
| Q2 24 | $36.0M | $55.4M | ||
| Q1 24 | $17.7M | $26.0M |
毛利率HNIRVTY
| Q4 25 | — | — | ||
| Q3 25 | 42.1% | 53.6% | ||
| Q2 25 | 42.9% | 54.5% | ||
| Q1 25 | 39.7% | 56.5% | ||
| Q4 24 | 40.5% | — | ||
| Q3 24 | 41.5% | 56.3% | ||
| Q2 24 | 41.9% | 55.7% | ||
| Q1 24 | 39.6% | 54.6% |
营业利润率HNIRVTY
| Q4 25 | — | 14.5% | ||
| Q3 25 | 9.4% | 11.7% | ||
| Q2 25 | 10.2% | 12.6% | ||
| Q1 25 | 4.1% | 10.9% | ||
| Q4 24 | 8.5% | 16.3% | ||
| Q3 24 | 10.2% | 14.3% | ||
| Q2 24 | 8.6% | 12.4% | ||
| Q1 24 | 5.1% | 6.8% |
净利率HNIRVTY
| Q4 25 | — | 12.7% | ||
| Q3 25 | 6.0% | 6.7% | ||
| Q2 25 | 7.2% | 7.5% | ||
| Q1 25 | 2.3% | 6.4% | ||
| Q4 24 | 6.0% | 13.0% | ||
| Q3 24 | 7.1% | 13.8% | ||
| Q2 24 | 5.8% | 8.0% | ||
| Q1 24 | 3.0% | 4.0% |
每股收益（稀释后）HNIRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | $0.88 | $0.40 | ||
| Q2 25 | $1.02 | $0.46 | ||
| Q1 25 | $0.29 | $0.35 | ||
| Q4 24 | $0.78 | $0.77 | ||
| Q3 24 | $0.98 | $0.77 | ||
| Q2 24 | $0.75 | $0.45 | ||
| Q1 24 | $0.37 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.1M | $919.9M |
| 总债务越低越好 | $324.2M | — |
| 股东权益账面价值 | $835.9M | $7.3B |
| 总资产 | $1.8B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.39× | — |
8季度趋势，按日历期对齐
现金及短期投资HNIRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | $28.1M | $931.4M | ||
| Q2 25 | $38.2M | $991.8M | ||
| Q1 25 | $27.5M | $1.1B | ||
| Q4 24 | $28.9M | $1.2B | ||
| Q3 24 | $40.2M | $1.2B | ||
| Q2 24 | $33.5M | $2.0B | ||
| Q1 24 | $32.5M | $1.7B |
总债务HNIRVTY
| Q4 25 | — | — | ||
| Q3 25 | $324.2M | — | ||
| Q2 25 | $444.4M | — | ||
| Q1 25 | $404.7M | — | ||
| Q4 24 | $344.6M | — | ||
| Q3 24 | $345.4M | — | ||
| Q2 24 | $462.3M | — | ||
| Q1 24 | $473.0M | — |
股东权益HNIRVTY
| Q4 25 | — | $7.3B | ||
| Q3 25 | $835.9M | $7.4B | ||
| Q2 25 | $811.0M | $7.6B | ||
| Q1 25 | $803.6M | $7.6B | ||
| Q4 24 | $840.1M | $7.7B | ||
| Q3 24 | $846.6M | $7.9B | ||
| Q2 24 | $787.8M | $7.9B | ||
| Q1 24 | $771.5M | $7.8B |
总资产HNIRVTY
| Q4 25 | — | $12.2B | ||
| Q3 25 | $1.8B | $12.1B | ||
| Q2 25 | $1.9B | $12.4B | ||
| Q1 25 | $1.9B | $12.4B | ||
| Q4 24 | $1.9B | $12.4B | ||
| Q3 24 | $1.9B | $12.8B | ||
| Q2 24 | $1.9B | $13.4B | ||
| Q1 24 | $1.9B | $13.4B |
负债/权益比HNIRVTY
| Q4 25 | — | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.41× | — | ||
| Q2 24 | 0.59× | — | ||
| Q1 24 | 0.61× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $155.2M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $135.6M | $161.8M |
| 自由现金流率自由现金流/营收 | 19.8% | 21.0% |
| 资本支出强度资本支出/营收 | 2.9% | 2.6% |
| 现金转化率经营现金流/净利润 | 3.77× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $189.5M | $509.4M |
8季度趋势，按日历期对齐
经营现金流HNIRVTY
| Q4 25 | — | $182.0M | ||
| Q3 25 | $155.2M | $138.5M | ||
| Q2 25 | $31.1M | $134.3M | ||
| Q1 25 | $12.6M | $128.2M | ||
| Q4 24 | $51.2M | $174.2M | ||
| Q3 24 | $128.5M | $147.9M | ||
| Q2 24 | $51.3M | $158.6M | ||
| Q1 24 | $-4.3M | $147.6M |
自由现金流HNIRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | $135.6M | $120.0M | ||
| Q2 25 | $16.1M | $115.5M | ||
| Q1 25 | $-3.7M | $112.2M | ||
| Q4 24 | $41.5M | $149.8M | ||
| Q3 24 | $114.0M | $125.6M | ||
| Q2 24 | $33.8M | $136.6M | ||
| Q1 24 | $-15.5M | $129.7M |
自由现金流率HNIRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | 19.8% | 17.2% | ||
| Q2 25 | 2.4% | 16.0% | ||
| Q1 25 | -0.6% | 16.9% | ||
| Q4 24 | 6.5% | 20.5% | ||
| Q3 24 | 17.0% | 18.4% | ||
| Q2 24 | 5.4% | 19.7% | ||
| Q1 24 | -2.6% | 20.0% |
资本支出强度HNIRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | 2.9% | 2.6% | ||
| Q2 25 | 2.2% | 2.6% | ||
| Q1 25 | 2.7% | 2.4% | ||
| Q4 24 | 1.5% | 3.4% | ||
| Q3 24 | 2.2% | 3.3% | ||
| Q2 24 | 2.8% | 3.2% | ||
| Q1 24 | 1.9% | 2.7% |
现金转化率HNIRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | 3.77× | 2.97× | ||
| Q2 25 | 0.65× | 2.49× | ||
| Q1 25 | 0.91× | 3.03× | ||
| Q4 24 | 1.34× | 1.84× | ||
| Q3 24 | 2.71× | 1.57× | ||
| Q2 24 | 1.43× | 2.87× | ||
| Q1 24 | -0.24× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HNI
| Systems Storage And Table | $309.9M | 45% |
| Residential Building Products | $166.9M | 24% |
| Seating Products | $161.1M | 24% |
| Other Products | $45.9M | 7% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
